HBZ and lymphoma: Also, it has recently been reported that HBZ-targeted vaccination by recombinant vaccinia viruses could induce CTLs, which have an anti-lymphoma effect in mouse and macaque models of ATL, suggesting the potential of HBZ as a target antigen for immunotherapy [18].